top of page

        上海益基诺生物医学科技有限公司成立于2025年3月（注册资本50万元），是一家专注于基因治疗药物研发的生物医药高科技企业。公司注册地址位于上海市徐汇区肇嘉浜路361号复医创新创业中心（复旦上海医学院分子生物创新孵化中心），依托复旦大学上海医学院优势学科和创新资源，在政府和六七八九科技集团等多方支持下，共享创新孵化平台的科研和产业资源。公司依托该平台和顶尖高校，汇聚生命健康领域创新生态，站在世界生物医学科技发展前沿，着眼未来革命性医疗模式变革，融合传统中医药的精华和人工智能（AI）技术，打造世界领先的通用性基因治疗药物创制平台，为基因治疗新药开发提供专业支撑，推动人类社会进步，助力国家强盛。

        Shanghai Yijinuo Biomedical Technology Co., Ltd. was established in March 2025 (registered capital of RMB 500,000). It is a high-tech biomedical enterprise focusing on the research and development of gene therapy drugs. The company's registered address is located at Fuyi Innovation and Entrepreneurship Center (Molecular Biology Innovation Incubation Center of Fudan Shanghai Medical College), No. 361, Zhaojiabang Road, Xuhui District, Shanghai. Relying on the advantageous disciplines and innovation resources of Shanghai Medical College of Fudan University, with the support of the government and 6789 Technology Group, it shares the scientific research and industrial resources of the innovation incubation platform. Relying on this platform and top universities, the company gathers an innovative ecology in the field of life and health, stands at the forefront of the development of biomedical science and technology in the world, focuses on the revolutionary medical model changes in the future, integrates the essence of traditional Chinese medicine and artificial intelligence (AI) technology, and creates a world-leading universal gene therapy drug creation platform, providing professional support for the development of new gene therapy drugs, promoting the progress of human society, and helping the country to become stronger.

OUR CORE VALUES

1dd8c5d19a865685429ce974026e1886.png

  • 使命（Mission）：

  • 依托基因编辑、中医药精髓与AI智能分析，我们致力于开发安全、精准、高效的一次性根治性新药，提升患者生命质量。

  • Leveraging gene editing, the essence of Traditional Chinese Medicine, and AI-driven analytics, we are committed to developing safe, precise, and one-time curative therapeutics that enhance patient quality of life.

  •  

  • 愿景（Vision）：

  • 成为全球领先的“三医融合”创新平台，引领基因治疗与中医现代化的深度融合，推动精准医疗迈向新纪元。

  •  To become the world’s leading “Gene-TCM-AI” innovation platform, pioneering the deep integration of gene therapy with modernized TCM, and ushering in a new era of precision medicine.

bottom of page